2[2]Inomata S,Itoh M,Imai H,et al.Seram levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy.Nephron,1997,75(4):426-430
3[3]Kuriyama S,Tomonari H,Yoshida H,et al.Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure especially in nondiabetic patients.Nephron,1997,77(2):176-185
4GIUSEPPE REMUZZI MD, ARRIGO SCHIPPATI MD. PIERO RUGGENENTI MD. Nephropathy in patients with type 2 diabetes. N Engl J Med.2002,346(15):1145-1150.
5Herrera AH,Lowenthal DT. Hypertention and ischemic nephropathy and its association with renal failure in the elderly. Geriatr nephrol Uroi,1997,7(3):167-170.
8Ruiz - Ortega M, Bustos C, Hernandez - Presa MA. Angiotensin Ⅱ participates in mononuclear cell recruitment in experimental im mune complex nephritis through nuclear factor - kappa B activation and monocyte chemoattractant protein - 1 synthesis[J]. J Immunol,1998,161:430 - 439.
9Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis : effect of monotherapy and combination therapy with inhibitor of the rennin-angiotensin system on proteinuria in renal disease[ J]. Ann Intern Med ,2008, 148( 1 ) :30-48.
